Compare VTR & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTR | CBOE |
|---|---|---|
| Founded | 1983 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Investment Bankers/Brokers/Service |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 25.6B |
| IPO Year | 1998 | 2010 |
| Metric | VTR | CBOE |
|---|---|---|
| Price | $79.56 | $249.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 11 |
| Target Price | $78.43 | ★ $244.64 |
| AVG Volume (30 Days) | ★ 3.3M | 723.9K |
| Earning Date | 10-29-2025 | 02-06-2026 |
| Dividend Yield | ★ 2.40% | 1.16% |
| EPS Growth | N/A | ★ 26.68 |
| EPS | 0.53 | ★ 9.30 |
| Revenue | ★ $5,544,046,000.00 | $4,617,800,000.00 |
| Revenue This Year | $17.34 | N/A |
| Revenue Next Year | $10.07 | $5.52 |
| P/E Ratio | $151.48 | ★ $26.74 |
| Revenue Growth | 16.38 | ★ 16.74 |
| 52 Week Low | $56.68 | $187.30 |
| 52 Week High | $81.89 | $262.98 |
| Indicator | VTR | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 46.08 |
| Support Level | $77.20 | $244.74 |
| Resistance Level | $80.13 | $253.70 |
| Average True Range (ATR) | 1.59 | 4.41 |
| MACD | -0.28 | -0.83 |
| Stochastic Oscillator | 63.65 | 36.27 |
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.